Table 2: Results of the variable analysis between the “with DVT” and “without DVT” groups.
Variable“With DVT”
𝑀 ± S D 		“Without DVT”
𝑀 ± S D 		P value
Hemoglobin (g/dL) 1 4 . 1 ± 2 . 7 1 2 . 9 ± 1 . 6 0.3
Hematocrit (%) 4 1 . 9 ± 7 . 1 3 7 . 2 ± 4 . 4 0.05
Prednisone dose/weight (mg/kg) 1 ± 0 . 6 0 . 7 9 ± 0 . 7 0.657
Total cholesterol (mg/dL) 5 4 7 . 3 ± 2 2 8 . 4 3 7 6 , 9 ± 2 1 0 , 3 0.074
Triglycerides (mg/dL) 4 3 0 . 6 ± 2 5 6 . 4 1 9 0 . 9 ± 9 4 0.008
HDL (mg/dL) 4 2 . 5 ± 4 . 8 5 3 6 . 8 ± 1 0 . 5 0.225
Platelet number (mm3) 4 1 9 5 4 5 . 5 ± 1 2 7 5 1 3 . 4 4 0 0 8 1 8 . 2 ± 1 2 0 9 2 4 . 6 0.507
Albumin (g/dL) 1 . 2 ± 0 . 3 2 1 . 4 1 ± 0 . 5 0.959
Serum creatinine (mg/dL) 0 . 4 3 ± 0 . 3 7 0 . 3 8 ± 0 . 2 2 0.959
Weight gain during hospitalization (%) 1 2 ± 9 . 6 8 . 7 5 ± 5 . 6 0.248
n (%)n (%)
History of dehydration3 (27%)0 (0%)0.107
Use of spironolactone6 (55%)5 (45%)0.5
Use of furosemide0%3 (27%)0.107
Use of another immunosuppressant2 (18%)2 (18%)0.707
Use of ASA2 (18%)1 (9%)0.5
Trauma0 (0%)0 (0%)—
Infection or severe systemic event9 (81%)3 (27%)0.015
M: mean; SD: standard deviation; ASA: acetylsalicylic acid.